News & Analysis as of

Risk-Based Approaches Regulatory Oversight

ArentFox Schiff

FDA Releases its Expanded Decision Tree, a New Tool for Toxicity Screening of Chemicals in Food

ArentFox Schiff on

On July 30, the US Food and Drug Administration (FDA) released its Expanded Decision Tree (EDT), a new science-based tool designed to screen and evaluate the safety or toxicity of chemicals in food....more

Baker Donelson

EU AI Act Tightens Grip on High-Risk AI Systems: Five Critical Questions for U.S. Companies

Baker Donelson on

A new era of AI legislation has begun as the EU AI Act enters into force on August 1, 2024. With broad extraterritorial reach, significant penalties of up to seven percent of worldwide annual turnover, and an emphasis on...more

Latham & Watkins LLP

EU AI Act: Navigating a Brave New World

Latham & Watkins LLP on

After three years of legislative debate, the Council of the European Union cast its final vote on the European Union (EU) Artificial Intelligence (AI) Act on 21 May 2024. Once published in the EU Official Journal in June, the...more

Ankura

The EU’s AI Act: Obligations of AI Users and GDPR Article 35

Ankura on

In December 2023, European Union (EU) lawmakers reached an agreement on the EU AI Act. In our article titled An Introduction to the EU AI Act, we focused on applicability, thresholds, timing, and penalties related to the EU...more

Baker Donelson

Who's Who under the EU AI Act: Spotlight on Key Actors

Baker Donelson on

Who will play the leading role if we make a new series about AI? If you interview Steven Spielberg, Sundar Pichai, and Sam Altman, you might receive three distinct ideas ranging from the 2001 classic "AI: Artificial...more

Benesch

European Union Artificial Intelligence Act: An Overview

Benesch on

On March 13, 2024, the EU AI Act received its final assent from the EU Parliament with 523 votes in favor, 46 against and 49 abstentions, bringing it one step closer to adoption. Minor linguistic changes are still to be...more

Morgan Lewis - All Things FinReg

Basel Committee Proposes Risk-Based Regulatory Capital Treatment for Many Cryptoassets

The Basel Committee on Banking Supervision (Basel Committee), a committee of global central bankers and regulators, issued a Consultative Document on June 10 on the prudential treatment of cryptoasset exposures for...more

A&O Shearman

Financial Action Task Force Consults on Digital Identity in Customer Due Diligence Guidance

A&O Shearman on

The Financial Action Task Force is seeking feedback from private sector stakeholders on its draft guidance on the use of digital identity systems in customer due diligence. The guidance will supplement Recommendation 10 of...more

Stinson LLP

FDA Issues a Second Draft Guidance on Clinical Decision Support Software

Stinson LLP on

On September 27, 2019, FDA issued a new draft guidance on Clinical Decision Support Software, supplanting its 2017 draft guidance, Clinical and Patient Decision Support Software. ...more

Ballard Spahr LLP

What the Basel AML Index Reveals About Global Money Laundering Risks

Ballard Spahr LLP on

Established in 2003, the Basel Institute is a not-for-profit Swiss foundation dedicated to working with public and private partners around the world to prevent and combat corruption, and is an Associated Institute of the...more

Hogan Lovells

Insurance Horizons 2018

Hogan Lovells on

Our Insurance Horizons 2018 brochure considers the impact of technology, interest rates, protectionism, excess capacity in the reinsurance market and cyber risk. We also look in detail at M&A in the industry, sanctions and...more

Hogan Lovells

Obtaining FDA clearance or approval of digital health products

Hogan Lovells on

Many digital health products are regulated by the U.S. Food and Drug Administration (FDA) as medical devices or, when used in conjunction with a specific drug or biological product, as combination products requiring clearance...more

K2 Integrity

April 15 Isn’t Just Tax Day—It’s Also AML Certification Compliance Day

K2 Integrity on

It’s not just your taxes that are due each year on April 15. For financial institutions, this coming April 15 is the date the New York Department of Financial Services’ (NYDFS’s ) new Anti-Money Laundering (AML) Part 504...more

Hogan Lovells

FDA Issues New Guidance Documents on Regenerative Medicine but Delays Enforcement

Hogan Lovells on

Last week, the U.S. Food and Drug Administration (FDA) announced a comprehensive framework for development and oversight of regenerative medicine products, including innovative cell-based therapies. ...more

14 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide